List view / Grid view
Wayne Pines, President of Healthcare at APCO Worldwide in Washington DC and a former Associate Commissioner of the FDA believes Milan is a logical choice for the relocation of the European Medicines Agency...
The UK's proposed withdrawal from Euratom may threaten the supply of essential medical isotopes, putting cancer patients at risk...
Automation and 3D printing to environmental regulations are now spelling the beginning of the end for globalised manufacturing...
Niall Dickson responds to the commitment by the secretaries of state to seek a collaborative relationship with the EU in medicines regulation and supply...
The ABPI has responded to a joint letter from Jeremy Hunt, Secretary of State for Health, and Greg Clark, Secretary of State for Business, published by the Financial Times, that outlined the UK Government’s plans for the regulation of medicines as the UK leaves the European Union (EU).
A year on from the Brexit referendum, Dr Penny Owen outlines the potential risks this vote could have on the life science industry and how to prepare for leaving the EU...
Independent health economist lays out solution for how the UK could handle pharmaceutical regulation after Brexit.
The FDA has approved BioMarin Pharmaceutical’s bulk biologics manufacturing plant, located in Cork, Ireland for production of the formulated bulk substance.
Hitesh Dodhia, Superintendent Pharmacist at Pharmacy Outlet, discusses the announcement of a hung parliament and what it means for UK healthcare...
2 June 2017 | By Niamh Marriott, Junior Editor
Sara Rajeswaran has joined the Association of the British Pharmaceutical Industry as the new Executive Director of Government Affairs and Devolved Nations.
15 May 2017 | By Niamh Marriott, Junior Editor
Antalis Packaging says that it is now more important than ever for companies to be watchful on their corrugated box specification and quality...
13 February 2017 | By Dr Penny Owen, Life Sciences Hub Wales
From government regulation to European trade, Life Sciences Hub Wales chairperson, Dr Penny Owen, looks ahead to the unknown of a post-Brexit world...
3 November 2016 | By Wickham Laboratories Limited
Wickham Laboratories will be on Stand 8 at the 24th Annual Pharmig Conference in the Nottingham Belfry Hotel, November 16th & 17th...
11 October 2016 | By Vanessa Rieu and Annsley Merelle Ward
Vanessa Rieu and Annsley Merelle Ward explain how life sciences companies can leverage their knowledge of national patent laws in a post-Brexit Europe...
27 June 2016 | By Victoria White, Digital Content Producer
While a Brexit undoubtedly creates significant issues for the UK pharma industry, opportunities remain for the sector to thrive, according to GlobalData...
